UCB revs up its gene therapy drive with Handl acquisitionUCB has made a new foray into the gene therapy space, buying fellow Belgium-based company Handl to get Share XUCB revs up its gene therapy drive with Handl acquisitionhttps://pharmaphorum.com/news/ucb-revs-up-its-gene-therapy-drive-with-handl-acquisition/
Sarepta dives deeper into gene therapySarepta Therapeutics has handed $30 million to Lacerta in exchange for a group of gene therapies, including a Share XSarepta dives deeper into gene therapyhttps://pharmaphorum.com/news/sarepta-dives-deeper-gene-therapy/
